Immunotherapy of B-16 melanoma with peptidoglycan monomer
- 1 May 1983
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (5) , 681-686
- https://doi.org/10.1016/0277-5379(83)90185-2
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Regression of Tumors in Guinea Pigs After Treatment with Synthetic Muramyl Dipeptides and Trehalose DimycolateScience, 1980
- Immunotherapy of an ascitic rat hepatoma with cord factor (trehalose‐6, 6′‐dimycolate) and synthetic analoguesInternational Journal of Cancer, 1979
- Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptideCellular Immunology, 1979
- Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex excreted into the medium by penicillin-treated Brevibacterium divaricatum mutantBiochimica et Biophysica Acta (BBA) - General Subjects, 1979
- Reduction of tumour cell entry into vessels by BCG-activated macrophagesBritish Journal of Cancer, 1977
- Metastasis Results from Preexisting Variant Cells Within a Malignant TumorScience, 1977
- Immunological mechanisms in metastatic spread and the antimetastatic effects of C. parvumBritish Journal of Cancer, 1977
- Mode of Immunosuppressive Action of Ehrlich Ascitic Fluid 2JNCI Journal of the National Cancer Institute, 1974
- Immunotherapy of Cancer: Regression of Established Intradermal Tumors After Intralesional Injection of Mycobacterial Cell Walls Attached to Oil DropletsJNCI Journal of the National Cancer Institute, 1974
- Isolation and Study of the Composition of a Peptidoglycan Complex Excreted by the Biotin‐Requiring Mutant of Brevibacterium divaricatum NRRL‐2311 in the Presence of PenicillinEuropean Journal of Biochemistry, 1974